Press Releases Olink Holding AB

Equities

OLK

US6807101000

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
24.45 ^USD	+0.20%		+1.83%	-2.78%

08:00am	Olink® Target 48 Immune Surveillance Panel ? the Next Frontier in Immune Biomarker Profiling with Absolute Confidence	CI
May. 30	Researchers Use Olink®? Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence	02:00am	GL
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	May. 30	GL
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis	May. 30	AQ
Olink reports first quarter 2024 financial results	May. 13	GL
Sampled Named One of the First Olink Certified Service Providers	May. 06	AQ
Olink : Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability - Form 6-K	Apr. 19	PU
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024	Apr. 19	GL
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease	Apr. 02	GL
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease	Apr. 02	AQ
Olink publishes 2023 annual report	Mar. 25	GL
Olink publishes 2023 annual report	Mar. 25	AQ
Olink reports fourth quarter and full year 2023 financial results	Mar. 25	GL
Notice to attend the Annual General Meeting of Olink Holding AB (publ)	Mar. 15	GL
Olink announces change of date for Annual General Meeting	Mar. 08	GL
Olink announces change of date for Annual General Meeting	Mar. 08	AQ
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink	Mar. 04	AQ
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools	Dec. 20	AQ
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink	Dec. 18	AQ
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink	Dec. 04	AQ
Olink reports third quarter 2023 financial results	Nov. 15	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Olink Holding AB

Equities

OLK

US6807101000

Press Releases

Filters